HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.

Deeks, S. G, Phillips, A. N·2009·BMJ
DOI 10.1136/bmj.a3172

Cited by (702)

Items 301–400 of 702

  1. Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals
    Javier Juega, Anna Bonjoch, Núria Pérez‐Álvarez, Eugènia Negredo, Beatriu Bayés, Josep Bonet, Buenaventura Clotet, Ramón Romero · 2017 · Medicine
  2. Community-Driven Health Priorities for Healthy Aging With HIV
    Brandon J. Brown, Logan Z. Marg, Alejandra Cabral, Michelle Didero, Christopher J. Christensen, Jeff Taylor, Andrew M. Subica · 2019 · Journal of the Association of Nurses in AIDS Care
  3. Increased carotid artery wall stiffness and plaque prevalence in HIV infected patients measured with ultrasound elastography
    Marie‐Hélène Roy Cardinal, Madéleine Durand, Carl Chartrand‐Lefebvre, Claude Fortin, Jean-Guy Baril, Benoît Trottier, Jean‐Pierre Routy, Gilles Soulez, Cecile L. Tremblay, Guy Cloutier · 2020 · European Radiology
  4. Potential Health Impacts of Heavy Metals on HIV-Infected Population in USA
    Xiaohui Xu, Hui Zheng Hu, Amy B. Dailey, Gregory Dale Kearney, Evelyn O. Talbott, Robert L. Cook · 2013 · PLoS ONE
  5. The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá
    Mark JM Van Duin, Rafael Conde, Ben F. M. Wijnen, Silvia Evers, Javier Leonardo González Rodríguez, Mark Govers, Mickaël Hiligsmann · 2016 · Expert Review of Pharmacoeconomics & Outcomes Research
  6. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection
    Kewreshini K. Naidoo, Okechukwu C. Ndumnego, Nasreen Ismail, Krista L. Dong, Thumbi Ndung’u · 2021 · Frontiers in Immunology
  7. 48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort
    Alfonso Cabello, Juan Carlos López Bernardo de Quirós, Luz Martín‐Carbonero, Jesús Sanz, Jorge Vergas, Álvaro Mena, Miguel Torralba, Marta Hernández Segurado, Adriana Pinto, Francisco Tejerina et al. · 2022 · PLoS ONE
  8. Living with HIV and Getting Vaccinated: A Narrative Review
    Andrea DE VITO, Agnese Colpani, Mattia Trunfio, Vito Fiore, Giulia Moi, Marco Fois, Nicola Leoni, Stefano Ruiu, Sergio Babudieri, Andrea Calcagno et al. · 2023 · Vaccines
  9. Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa
    G. Emerens Wensink, Annelot F. Schoffelen, Hugo A. Tempelman, Maarten B. Rookmaaker, Andy I. M. Hoepelman, Roos E. Barth · 2015 · PLoS ONE
  10. A novel symptom cluster analysis among ambulatory HIV/AIDS patients in Uganda
    Eve Namisango, Richard Harding, Elly Tebasoboke Katabira, Richard John Siegert, Richard A. Powell, Leonard K Atuhaire, Katrien Moens, S. Mark Taylor · 2015 · AIDS Care
  11. Inflammatory Biomarker Changes and Their Correlation with Framingham Cardiovascular Risk and Lipid Changes in Antiretroviral-Naive HIV-Infected Patients Treated for 144 Weeks with Abacavir/Lamivudine/Atazanavir with or without Ritonavir in ARIES
    Benjamin Young, Kathleen Squires, Lisa Ross, Lizette Santiago, Louis M. Sloan, Henry H. Zhao, Brian Wine, Gary E. Pakes, David A. Margolis, Mark S. Shaefer · 2012 · AIDS Research and Human Retroviruses
  12. Serum Adenosine Deaminase and Total Immunoglobulin G Correlate with Markers of Immune Activation and Inversely with CD4 Counts in Asymptomatic, Treatment-Naive HIV Infection
    Hayley Ipp, Annalise E. Zemlin, Richard Helmuth Glashoff, Johan van Wyk, Naadira Vanker, Tim Reid, Linda‐Gail Bekker · 2012 · Journal of Clinical Immunology
  13. HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
    Katleen de Gaetano Donati, Roberto Cauda, Licia Iacoviello · 2010 · Mediterranean Journal of Hematology and Infectious Diseases
  14. Thirty years of the human immunodeficiency virus epidemic and beyond
    F. Younai · 2013 · International Journal of Oral Science
  15. Trends in Comorbid Conditions Among Medicaid Enrollees With HIV
    Megan B. Cole, Omar Galárraga, Momotazur Rahman, Ira B. Wilson · 2019 · Open Forum Infectious Diseases
  16. Senotherapeutics for HIV and aging
    Matthew A. Szaniawski, Adam M. Spivak · 2019 · Current Opinion in HIV and AIDS
  17. Can time-related patterns in diagnosis for hospital admission help identify common root causes for disease expression?
    Rod Jones · 2010 · Medical Hypotheses
  18. Association of the Veterans Aging Cohort Study Index with Exercise Capacity in HIV-Infected Adults
    Krisann K. Oursler, Janet P. Tate, Thomas M. Gill, Kristina A. Crothers, Todd Tarquin Brown, Stephen Crystal, Julie A. Womack, David A. Leaf, John David Sorkin, Amy C. Justice · 2013 · AIDS Research and Human Retroviruses
  19. What are the essential components of HIV treatment and care services in low and middle-income countries
    Paula Munderi, Heiner Grosskurth, Benson Droti, David Anthony Ross · 2012 · AIDS
  20. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy
    Laura Galli, Vincenzo Spagnuolo, Andrea Poli, Stefania Salpietro, Nicola Gianotti, Francesca Cossarini, Alessia Carbone, Silvia Nozza, Simona Bossolasco, Alba Bigoloni et al. · 2014 · AIDS
  21. Effective prediction of drug – target interaction on HIV using deep graph neural networks
    Bihter Daş, Mucahit Kutsal, Resul Daş · 2022 · Chemometrics and Intelligent Laboratory Systems
  22. Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects
    Didier Scherrer, Regine Rouzier, P. Noel Barrett, Jean-Marc Steens, Paul Gineste, Robert L. Murphy, Jamal Tazi, Hartmut J. Ehrlich · 2016 · Journal of Antimicrobial Chemotherapy
  23. Pharmaceutical Approaches to HIV Treatment and Prevention
    Burçin Yavuz, Jessica L. Morgan, Laura Showalter, Katti R. Crakes, Satya Dandekar, Carolina Herrera, Patricia J. LiWang, David Lee Kaplan · 2018 · Advanced Therapeutics
  24. T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection
    Laurence Weiss, Mathieu F. Chevalier, Lambert Assoumou, Céline Didier, Pierre‐Marie Girard, Christophe Piketty, Dominique G. Costagliola, Christine Rouzioux · 2014 · AIDS
  25. Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort
    Serena Vita, Miriam Lichtner, Giulia Carla Marchetti, Claudia Mascia, Esther Merlini, Paola Cicconi, Vincenzo Vullo, Pierluigi Viale, Andrea Costantini, Antonella d’Arminio Monforte · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  26. The Impact of COVID-19 on Older Adults Living with HIV: HIV Care and Psychosocial Effects
    Monique J. Brown, Sharon Weissman · 2020 · Journal of Gerontological Social Work
  27. Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy
    Gaetano Maffongelli, Claudia Alteri, Elisa Gentilotti, Ada Bertoli, Alessandra Ricciardi, Vincenzo Malagnino, Valentina Svicher, Maria Mercedes Santoro, Luca Dori, Carlo Federico Perno et al. · 2015 · AIDS
  28. Shifting Dynamics of Intestinal Macrophages during Simian Immunodeficiency Virus Infection in Adult Rhesus Macaques
    Naofumi Takahashi, Chie Sugimoto, Carolina Allers, Xavier A. Alvarez, Woong‐Ki Kim, Elizabeth S. Didier, Marcelo J. Kuroda · 2019 · The Journal of Immunology
  29. Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995–2014
    Catherine R. Lesko, Richard D. Moore, Weiqun Tong, Bryan M. Lau · 2016 · AIDS
  30. Multimorbidity among people with HIV in regional New South Wales, Australia
    Edmiston, Natalie, Passmore, Erin, Smith, David J., Petoumenos, Kathy · 2015 · Sexual Health
  31. Bone Mineral Density Over 96 Weeks in Adults Failing First-Line Therapy Randomized to Raltegravir/Lopinavir/Ritonavir Compared With Standard Second-Line Therapy
    Hila Haskelberg, Patrick W. G. Mallon, Jennifer Hoy, Janaki Amin, Cecilia L. Moore, Praphan Phanuphak, Samuel Ferret, Waldo Horacio Belloso, Mark Alastair Boyd, David A. Cooper et al. · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  32. Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging
    Erin E. Sundermann, Kristine Mace Erlandson, Caitlin N. Pope, Anna Rubtsova, Jessica L. Montoya, Alison A. Moore, Catia Marzolini, Kelly Kathleen O’Brien, Savita G. Pahwa, Brendan A. I. Payne et al. · 2019 · AIDS Research and Human Retroviruses
  33. Prevalence of Physical Health, Mental Health, and Disability Comorbidities among Women Living with HIV in Canada
    Emily V. Heer, Angela Kaida, Nadia O’Brien, Bluma Kleiner, Alie Pierre, Danielle Rouleau, Ann N. Burchell, Lashanda Skerritt, Karène Proulx‐Boucher, Valerie Nicholson et al. · 2022 · Journal of Personalized Medicine
  34. Co-Creating Socio-Culturally-Appropriate Virtual Geriatric Care for Older Adults Living With HIV: A Community-Based Participatory, Intersectional Protocol
    Kristina Marie Kokorelias, Marina B. Wasilewski, Ashley K. Flanagan, Alice Zhabokritsky, Hardeep Singh, Erica Dove, Andrew David Eaton, Dean Valentine, Christine L. Sheppard, Reham Abdelhalim et al. · 2023 · International Journal of Qualitative Methods
  35. Torque teno virus: a potential marker of immune reconstitution in youths with vertically acquired HIV
    Laura Tarancón‐Díez, Itzíar Carrasco, Laura Montes, Iker Falces‐Romero, Elena Vázquez‐Alejo, Santiago Jiménez de Ory, Marta Dapena, José Antonio Iribarren, Cristina Díez, Luis Ramos‐Ruperto et al. · 2024 · Scientific Reports
  36. Inpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995–2007
    Frederik Neess Engsig, Ann‐Brit Eg Hansen, Jan Gerstoft, Gitte Kronborg, Carsten Schade Larsen, Niels Obel · 2010 · AIDS
  37. Relationship of Vitamin D, HIV, HIV Treatment, and Lipid Levels in the Women’s Interagency HIV Study of HIV-Infected and Uninfected Women in the United States
    Janice B. Schwartz, Kelly L. Moore, Michael T. Yin, Anjali Sharma, Dan Merenstein, Talat S. Islam, Elizabeth T. Golub, Phyllis C. Tien, Oluwatoyin M Adeyemi · 2014 · Journal of the International Association of Providers of AIDS Care (JIAPAC)
  38. Beneficial and Detrimental Effects of Antiretroviral Therapy on HIV-Associated Immunosenescence
    Ornella Franzese, Maria Luisa Barbaccia, Enzo Bonmassar, Grazia Graziani · 2018 · Chemotherapy
  39. Mortality and Causes of Death among Individuals Diagnosed with Human Immunodeficiency Virus in Korea, 2004–2018: An Analysis of a Nationwide Population-Based Claims Database
    Boyoung Park, Yunsu Choi, Jung Ho Kim, Hye Seong, Youn Jeong Kim, Myungsun Lee, Jaehyun Seong, Shin‐Woo Kim, Joon Young Song, Hee-Jung Choi et al. · 2022 · International Journal of Environmental Research and Public Health
  40. Improving combination antiretroviral therapy by targeting HIV-1 gene transcription
    Valentin Le Douce, Amina Aït-Ammar, Faezeh Forouzanfar, Faiza Fahmi, Jose Quiel, Hala El Mekdad, Fadoua Daouad, Céline Marban, Olivier Rohr, Christian Schwartz · 2016 · Expert Opinion on Therapeutic Targets
  41. Body burden of heavy metals among HIV high risk population in USA
    Xiaohui Xu, Hui Zheng Hu, Yan Alicia Hong · 2016 · Environmental Pollution
  42. Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study
    Hannock M. Tweya, Caryl Feldacker, Tom Heller, Salem Gugsa, Wingston Felix Ng’ambi, Omisher Nthala, Mike Kalulu, Jane Chiwoko, Rabecca Banda, Agness Makwinja et al. · 2017 · PLoS ONE
  43. Evolution of an International Research Collaborative in HIV and Rehabilitation: Community Engaged Process, Lessons Learned, and Recommendations
    Kelly Kathleen O’Brien, Patricia E. Solomon, Francisco Ibáñez-Carrasco, Will Chegwidden, Esther McDonnell, Darren A. Brown, Richard Harding, Colm J Bergin, Catherine Worthington, Stephen Tattle et al. · 2018 · Progress in community health partnerships
  44. Impact and correlates of sub-optimal social support among patients in HIV care
    Rob J. Fredericksen, Laura E. Gibbons, Emma Fitzsimmons, Robin M. Nance, Katherine R. Schafer, David Scott Batey, Stephanie S. Loo, Sarah Dougherty, William C. Mathews, Katerina Christopoulos et al. · 2021 · AIDS Care
  45. HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 “Aging” Study
    Sophie Perrin, Jonathan Cremer, Olivia Zaegel‐Faucher, Jacques Reynes, P. Dellamonica, Joëlle Micallef, Caroline Solas, Bruno Lacarelle, Charlotte Stretti, Élise Kaspi et al. · 2012 · PLoS ONE
  46. Risk of Myocardial Infarction in Parents of HIV-infected Individuals:a population-based Cohort Study
    Line Dahlerup Rasmussen, Lars Haukali Omland, Court Pedersen, Jan Gerstoft, Gitte Kronborg, Janne Jensen, Niels Obel · 2010 · BMC Infectious Diseases
  47. Risk of Deaths, AIDS-Defining and Non-AIDS Defining Events among Ghanaians on Long-Term Combination Antiretroviral Therapy
    Fred Stephen Sarfo, Maame Anima Sarfo, Betty Norman, Richard Odame Phillips, George Bedu‐Addo, David Chadwick · 2014 · PLoS ONE
  48. HealthMap: a cluster randomised trial of interactive health plans and self-management support to prevent coronary heart disease in people with HIV
    Sarity Dodson, Karen Klassen, Karalyn McDonald, Tanya Nicole Millard, Richard H. Osborne, Malcolm Battersby, Christopher Kincaid Fairley, Julie Anne Simpson, Paula Kate Lorgelly, Andrew Maxwell Tonkin et al. · 2016 · BMC Infectious Diseases
  49. Optimal Probability Weights for Inference With Constrained Precision
    Michele Santacatterina, Matteo Bottai · 2017 · Journal of the American Statistical Association
  50. Longitudinal evaluation of resting-state connectivity, white matter integrity and cortical thickness in stable HIV infection: Preliminary results
    Diogo Goulart Corrêa, Nicolle Zimmermann, Nina Ventura, Gustavo Tukamoto, Thomas Martin Doring, Sarah C.B. Leite, Rochele Paz Fonseca, Paulo Roberto Valle Bahia, Fernanda Cristina Rueda Lopes, Emerson L. Gasparetto · 2017 · The Neuroradiology Journal
  51. Causes of hospitalisation among a cohort of people with HIV from a London centre followed from 2011 to 2018
    Sophia M. Rein, Fiona C. Lampe, Clinton Chaloner, Adam Stafford, Alison J. Rodger, Margaret A. Johnson, Jeffrey McDonnell, Fiona M. Burns, Sara Madge, Alec H. Miners et al. · 2021 · BMC Infectious Diseases
  52. Defining multimorbidity in people with HIV – what matters most?
    Luxsena Sukumaran, Caroline Anne Sabin · 2023 · Current Opinion in HIV and AIDS
  53. HIV and aging: insights from the Asia Pacific HIV Observational Database ( APHOD )
    Ning Han, Stephen T. Wright, CC O’Connor, Jennifer Hoy, Sasheela S L Ponnampalavanar, Miriam Grotowski, HX Zhao, Adeeba Kamarulzaman, Australian HIV Observational Database (AHOD), TREAT Asia HIV Observational Database (TAHOD) · 2014 · HIV Medicine
  54. Attitude of patients with HIV infection towards organ transplant between HIV patients. A cross-sectional questionnaire survey
    Huda Taha, Katie V. Newby, Archik Das, Satyajit Das · 2015 · International Journal of STD & AIDS
  55. Religious Congregations and the Growing Needs of Older Adults with HIV
    Mark Brennan‐Ing, Shiela M. Strauss, Stephen E. Karpiak · 2010 · Journal of Religion Spirituality & Aging
  56. Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients
    The Polish Observational Cohort of HIV/AIDS Patients (POLCA) Study Group, Justyna Dominika Kowalska, Joanna Kubicka, Ewa Siwak, Piotr Pulik, Ewa Firląg‐Burkacka, Andrzej Horban · 2016 · AIDS Research and Therapy
  57. Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy
    Hugo Ribeiro Zanetti, Edmar Lacerda Mendes, Antônio Carlos Palandri Chagas, Maria Odila Gomes Douglas, Leandro Teixeira Paranhos Lopes, Leonardo Roever, Alexandre Gonçalves, Elmiro Santos Resende · 2018 · Current Atherosclerosis Reports
  58. Approaches to Improve the Surveillance, Monitoring, and Management of Noncommunicable Diseases in HIV-Infected Persons: Viewpoint
    Pragna Patel, Keith M. Sabin, Peter Godfrey‐Faussett · 2018 · JMIR Public Health and Surveillance
  59. HIV infection is an independent risk factor for decreased 6-minute walk test distance
    Thomas Robertson, Mehdi syed Nouraie, Shulin Qin, Kristina A. Crothers, Cathy J. Kessinger, Deborah K. McMahon, Divay Chandra, Lawrence Kingsley, Ruth M. Greenblatt, Laurence Huang et al. · 2019 · PLoS ONE
  60. Dendritic Cell Immunoreceptor Is a New Target for Anti-AIDS Drug Development: Identification of DCIR/HIV-1 Inhibitors
    Alexandra A. Lambert, Arezki Azzi, Sheng‐Xiang Lin, Geneviève Allaire, Karianne P. St-Gelais, Michel J. Tremblay, Caroline Gilbert · 2013 · PLoS ONE
  61. Sex Disparities in Overall Burden of Disease Among HIV-Infected Individuals in the Veterans Affairs Healthcare System
    Oni J. Blackstock, Janet P. Tate, Kathleen M. Akgün, Stephen Crystal, Mona Duggal, Eva Jennifer Edelman, Cynthia L. Gibert, Kirsha S. Gordon, David Rimland, Maria C. Rodriguez‐Barradas et al. · 2013 · Journal of General Internal Medicine
  62. Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
    Ellen Eaton, Chastity McDavid, Mary K. Banasiewicz, Michael J. Mugavero, Sara J. Knight · 2017 · Patient Preference and Adherence
  63. Role of Killer cell immunoglobulin-like receptors (KIR) genes in stages of HIV-1 infection among patients from Burkina Faso
    Pegdwendé Abel Sorgho, Florencia Wendkuuni Djigma, Jeremy James Martinson, Albert Théophane Yonli, Bolni Marius Nagalo, Tégwindé Rébeca Compaore, Birama Diarra, Herman Karim Sombié, Abibou Simporé, Arsène Zongo et al. · 2019 · BioMolecular Concepts
  64. Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection
    Esaki Muthu Shankar · 2015 · World Journal of Virology
  65. Lung Cancer Screening in People With HIV: A Mixed-Methods Study of Patient and Provider Perspectives
    Matthew Triplette, Meagan C. Brown, Madison Snidarich, Jehan Z Budak, Nicholas Giustini, Nicholas R. Murphy, Perrin E. Romine, Bryan Jeffrey Weiner, Kristina A. Crothers · 2023 · American Journal of Preventive Medicine
  66. Comorbidity and polypharmacy among people with HIV stratified by age, sex, and race
    Misti L. Paudel, Girish Prajapati, Erin K. Buysman, Swarnali Goswami, Kimberly McNiff, Princy N. Kumar, Bekana K. Tadese · 2024 · HIV Research & Clinical Practice
  67. Protein Phosphatase-1 –targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals
    Xionghao Lin, Tatiana Ammosova, Namita Kumari, Sergei A. Nekhai · 2017 · Current Pharmaceutical Design
  68. The health-care needs of the older gay man living with HIV
    Ian Peate · 2013 · British Journal of Community Nursing
  69. HIV-associated kidney disease in the context of an aging population
    Claire M. Naftalin, Bavithra Nathan, Lisa Hamzah, Frank A. Post · 2011 · Sexual Health
  70. A descriptive, cross-sectional study examining treatment burden in people living with HIV
    Nathanial Schreiner, Joseph D. Perazzo, Jackson Currie, Barbra Daly, Allison R. Webel · 2019 · Applied Nursing Research
  71. Impact of tobacco smoke in HIV progression: a major risk factor for the development of NeuroAIDS and associated CNS disorders
    Aditya Bhalerao, Luca Cucullo · 2019 · Journal of Public Health
  72. A New Small-Molecule Compound, Q308, Silences Latent HIV-1 Provirus by Suppressing Tat- and FACT-Mediated Transcription
    Chenliang Zhou, Yifan Huang, Yi-bin Li, Taizhen Liang, Tengyi Zheng, Pei Chen, Ziyao Wu, Fang-yuan Lai, Shuwen Liu, Baomin Xi et al. · 2021 · Antimicrobial Agents and Chemotherapy
  73. Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania
    Lilian Nkinda, Eliud Buberwa, Peter T. N. Memiah, Alieth Ntagalinda, Martin George, Frank Msafiri, Agricola Joachim, Mtebe Venance Majigo, Kaushik L. Ramaiya, Bruno Fokas Sunguya · 2022 · Frontiers in Endocrinology
  74. Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing
    Joshua Dawe, Dean Cassano, Richard Keane, Simon Ruth, Anna Lee Wilkinson, Imogen A. Elsum, Jack Gunn, Graham Brown, Michael West, Jennifer Hoy et al. · 2023 · HIV Medicine
  75. Activation, senescence and inflammation markers in HIV patients
    Alexandra Ozanne, P. Duffau, Frédéric‐Antoine Dauchy, Claire Rigothier, Cécile Terrien, Estibaliz Lazaro, Charles Cazanave, Sylvie Lawson‐Ayayi, Fabrice Bonnet, Patrick Blanco et al. · 2017 · AIDS
  76. Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
    Samara Tatielle Monteiro Gomes, Érica Ribeiro Gomes, Mike Batista dos Santos, Sandra Souza Lima, Maria Alice Freitas Queiroz, Luiz Fernando Almeida Machado, Izaura Maria Vieira Cayres Vallinoto, Antônio Carlos Rosário Vallinoto, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak · 2017 · BMC Infectious Diseases
  77. The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age
    Jaime H. Vera, Akil Jackson, Laura Dickinson, Laura Else, Tristan Barber, Borja Mora‐Peris, David J. Back, Marta Boffito, Alan Winston · 2015 · HIV Clinical Trials
  78. HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients
    ALAN L. LANDAY, Elizabeth T. Golub, Seema N. Desai, Jinbing Zhang, Val Winkelman, Kathryn Anastos, Helen G. Durkin, Mary Young, Maria C. Villacres, Ruth M. Greenblatt et al. · 2013 · AIDS
  79. Comorbidity and polypharmacy among women living with HIV in British Columbia
    Mira A. Donaldson, Amber R Campbell, Arianne Albert, Mahtab Borhani, Ariel Nesbitt, Hélène C F Côté, Evelyn J. Maan, Neora Pick, Melanie C. M. Murray · 2019 · AIDS
  80. Life expectancy and mortality among males and females with HIV in British Columbia in 1996–2020: a population-based cohort study
    Katherine W. Kooij, Wendy Zhang, Jason Trigg, Nance E. Cunningham, Michael Owusu Budu, Megan E. Marziali, Viviane Dias Lima, Kate A. Salters, Rolando Barrios, Julio S. G. Montaner et al. · 2025 · The Lancet Public Health
  81. Growing Old with HIV
    Diixa Patel, Lawrence R. Crane · 2010 · Current Infectious Disease Reports
  82. Management of human immunodeficiency virus in older people
    Beng Eu, Ethan A. Salleh, Andrew J. Sakko, Giovanni Guaraldi · 2019 · Australian Journal of General Practice
  83. HIV and AIDS in Older Adults: Neuropsychiatric Changes
    Paroma Mitra, Ankit Jain, Katherine Kim · 2022 · Current Psychiatry Reports
  84. Correlation between CD4 / CD8 ratio and neurocognitive performance during early HIV infection
    Leah T. Le, Richard W. Price, Magnus Gisslén, Henrik Zetterberg, Brinda Emu, Roxane Fabre, Christian Pradier, Signe Andersen, Serena Spudich, Matteo Vassallo · 2022 · HIV Medicine
  85. In silico Design, Synthesis, and Screening of Novel Deoxyhypusine Synthase Inhibitors Targeting HIV‐1 Replication
    Marcus Schroeder, Adrian Kolodzik, Katharina Pfaff, Poornima Priyadarshini C. G., Marcel Krepstakies, Joachim Hauber, Matthias Rarey, Chris Meier · 2014 · ChemMedChem
  86. Human papilloma virus vaccination induces strong human papilloma virus specific cell-mediated immune responses in HIV-infected adolescents and young adults
    Veronica Rainone, Vania Giacomet, Francesca Penagini, Valentina Fabiano, Francesca Calascibetta, Chiara Mameli, Stefania Pisanelli, Gianvincenzo Zuccotti, Mario Clerici, Daria Trabattoni · 2015 · AIDS
  87. Pilot study assessing the Rotterdam Healthy Aging Score in a cohort of HIV-positive adults in Toronto, Canada
    Sharon Lynn Walmsley, Melody Ren, Ceylon Simon, Rosemarie Clarke, Leah Szadkowski · 2020 · AIDS
  88. Relationship Between Inflammatory and Coagulation Biomarkers and Cardiac Autonomic Function in HIV-Infected Individuals
    Lari C Young, Mollie Poehlman Roediger, Greg Grandits, Jason V. Baker, Charurut Somboonwit, Ian G. Williams, Jens Dilling Lundgren, James D. Neaton, Elsayed Z. Soliman · 2014 · Biomarkers in Medicine
  89. HIV and Aging
    Kris Ann Oursler, John David Sorkin · 2016 · International Journal of Infectious Diseases
  90. Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon
    Wellington Mota Gama, Carlos Henrique Michiles Frank, Taynná Vernalha Rocha Almeida, Daniel Silva Santos, Yury Oliveira Chaves, Danielle Furtado da Silva, Patrícia Puccinelli Orlandi, Flávio Ribeiro Pereira, Gleicienne Feliz Magalhães, Bárbara José Antunes Baptista et al. · 2021 · BMC Infectious Diseases
  91. An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV
    Harry A Mystakelis, Eleanor M. P. Wilson, Elizabeth Laidlaw, April L. Poole, Sonya Krishnan, Adam W. Rupert, Jorden L. Welker, Robert J. Gorelick, Andrea Lisco, Maura M. Manion et al. · 2023 · AIDS
  92. Nose-to-Brain delivery of antiretroviral drug loaded lipidic nanocarriers to purge HIV reservoirs in CNS: A safer approach
    Sonal Mehrotra, Salwa, Pavan Kalyan BG, Navya Ajitkumar Bhaskaran, Srinivas Reddy Jitta, Lalit Kumar · 2023 · Journal of Drug Delivery Science and Technology
  93. Metformin facilitates viral reservoir reactivation and their recognition by anti-HIV-1 envelope antibodies
    Augustine Fert, Jonathan Richard, Laurence Raymond Marchand, Delphine Planas, Jean‐Pierre Routy, Nicolas Chomont, Andrés Finzi, Petronela Ancuța · 2024 · iScience
  94. Engineered DNA modifying enzymes: Components of a future strategy to cure HIV/AIDS
    Frank Buchholz, Joachim Hauber · 2012 · Antiviral Research
  95. The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV
    Erin E. Sundermann, Rowan Saloner, Anna Rubtsova, Annie Lu Nguyen, Scott Lee Letendre, Raeanne C. Moore, Mariana Cherner, Qing Ma, María J. Marquine · 2022 · Journal of NeuroVirology
  96. Dolutegravir-containing HIV therapy reversibly alters mitochondrial health and morphology in cultured human fibroblasts and peripheral blood mononuclear cells
    Abhinav Ajaykumar, Loïc C. Caloren, Tetiana Povshedna, Anthony Y.Y. Hsieh, Aya Zakaria, Renying Cai, Marie-Soleil R. Smith, Connor A.H. Thompson, Pierre Becquart, Prakruti Uday et al. · 2022 · AIDS
  97. Deterioro cognitivo en adultos mayores con VIH/sida y síndrome de fragilidad
    Alfonso Zamudio‐Rodríguez, Sara G. Aguilar-Navarro, José Alberto Ávila‐Funes · 2017 · Gaceta Médica de México
  98. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study
    Cecilia Theresa Costiniuk, Joel Singer, Marc‐André Langlois, Iva Kulić, Judy Needham, Ann N. Burchell, Mohammad-Ali Jenabian, Sharon Lynn Walmsley, Mario Ostrowski, Colin M Kovacs et al. · 2021 · BMJ Open
  99. High frequency of deficient consumption and low blood levels of 25-hydroxyvitamin D in HIV-1-infected adults from São Paulo city, Brazil
    Stephanie Hael Sales, Sandra Maria Matta, Daniela Cardeal da Silva, Tatiane Assone, Luiz A.M. Fonseca, Alberto J.S. Duarte, Jorge Casseb · 2015 · Scientific Reports
  100. Reasons for Limiting Drinking in an HIV Primary Care Sample
    Jennifer C. Elliott, Efrat Aharonovich, Deborah S. Hasin · 2014 · Alcoholism Clinical and Experimental Research